Physician-reported factors that encourage collaboration with community pharmacists

Pezzino, Nicole C.; Marciniak, Macary Weck; Smith, Megan G.; Ferreri, Stefanie P.

doi:10.1016/j.japh.2017.02.016

Cited by 17 publications

(16 citation statements)

References 8 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Studies demonstrate that healthcare professionals can successfully partner informally with community pharmacists, [57][58][59][60][61][62][63] with the most successful physician-pharmacist relationships characterized by open communication, mutual trust, agreement on role specifications, and high-quality pharmacist contributions that are performed consistently and within a well-defined structure. 64,65 A strong working relationship between pharmacists and prescribers is necessary to optimize healthcare for each patient.…”

Section: Considerations For Incorporating Mtm Into the Health Care Teammentioning

confidence: 99%

<p>Medication Therapy Management: Current Challenges</p>

Ferreri¹,

Hughes²,

Snyder³

2020

IPRP

View full text Add to dashboard Cite

Medication therapy management (MTM) services have evolved as a means for pharmacists and other providers to assist patients and caregivers in improving therapeutic outcomes and reducing health care expenditures. More than a decade has passed since the Medicare Modernization Act of 2003 provided pharmacists with the opportunity to deliver MTM services to Medicare beneficiaries. MTM continues to offer pharmacists the opportunity to use their knowledge; yet, pharmacists have reported challenges with service delivery. Identifying the challenges that affect MTM services in pharmacy practice is necessary in order to seek improvement to MTM delivery. This narrative review explores the current challenges pharmacists face with MTM delivery, summarizes potential solutions for addressing challenges, and seeks to incite further debate, service reconfiguration, and ultimately service improvement of pharmacist-provided MTM services.

show abstract

Section: Considerations For Incorporating Mtm Into the Health Care Teammentioning

confidence: 99%

<p>Medication Therapy Management: Current Challenges</p>

Ferreri¹,

Hughes²,

Snyder³

2020

IPRP

View full text Add to dashboard Cite

show abstract

“…24,25 Only some of the practices and the pharmacies in the present study had access to the same EHR and documentation system, making communication and referral through these systems not possible for those without common access and increasing the challenges with referring patients. Similarly to current literature, 26 physicians in this study were receptive and valued the services that community pharmacies could provide; however, they were unaware of ways to best partner with them. Further research is warranted to determine the best workflow between practices and enhanced-service pharmacies.…”

Section: Discussionmentioning

confidence: 59%

Care team perspectives on community pharmacy enhanced services

Fay¹,

Ferreri²,

Shepherd³

et al. 2018

Journal of the American Pharmacists Association

Self Cite

View full text Add to dashboard Cite

show abstract

“…Additional corrections and changes will appear in this article when it is published in a future print issue. 6 monitoring. Upon receiving the referral, the clinical pharmacist screened the patient to determine whether they could be managed via a telephone encounter or if they required an in-person clinic visit.…”

Section: O N L I N E F I R S Tmentioning

confidence: 99%

“…The survey modeled previous studies assessing similar outcomes. [6][7][8] A total of 17 questions were included, 7 of which assessed providers' perceived impact of the clinical pharmacist on patient care and 10 assessed providers' satisfaction with the clinical pharmacist (Table S1). Both sections of the survey utilized a Likert scale for responses.…”

Section: Provider Surveymentioning

confidence: 99%

“…Although the survey was based on previous studies evaluating similar outcomes, [6][7][8] there was no formal process followed in survey development and the customized nature of the survey tool may not be generalizable to other institutions. Second, we were only able to capture interventions that were documented in the EMR of patients seen in the neurology clinic.…”

Section: O N L I N E F I R S Tmentioning

confidence: 99%

See 1 more Smart Citation

Incorporation and Impact of a Clinical Pharmacist in a Hospital-Based Neurology Clinic Treating Patients with Multiple Sclerosis

May¹,

Morgan²,

Quairoli³

2020

International Journal of MS Care

View full text Add to dashboard Cite

Background: Clinical pharmacists are uniquely positioned to assist with the complexities of medication management for patients with multiple sclerosis (MS). The objective of this study is to describe clinical pharmacy services provided as well as provider satisfaction and perceived impact of incorporating a clinical pharmacist in MS patient care. Methods: This study was conducted in two parts: a retrospective chart review and provider survey conducted in an outpatient neurology clinic at an academic medical center. Between April 2017 and June 2018, electronic medical records (EMRs) of patients with documented interventions by a pharmacist were reviewed to describe clinical pharmacy services provided to MS patients. A voluntary, anonymous survey was distributed to neurology providers to evaluate provider satisfaction and perceived impact of clinical pharmacist involvement in MS patient care. Results: There were 64 patients identified during the study period with 378 documented interventions made by clinical pharmacists. Pharmacist interventions were most commonly related to facilitating medication access (N=208), pre-treatment screening (N=57), patient counseling (N=51), and providing drug information (N=43). All providers surveyed (n=9) indicated that facilitating medication access, patient counseling, and drug interaction management were moderately or very important clinical pharmacy services. Furthermore, all providers surveyed strongly agreed that pharmacist involvement decreased time to therapy initiation for patients and decreased provider time spent on medication management. Conclusions: Clinical pharmacists play an integral role in MS patient care, particularly with facilitating medication access. Prospective studies are needed to further evaluate the contribution of clinical pharmacists in the care of MS patients.

show abstract

Physician-reported factors that encourage collaboration with community pharmacists

Cited by 17 publications

References 8 publications

<p>Medication Therapy Management: Current Challenges</p>

<p>Medication Therapy Management: Current Challenges</p>

Care team perspectives on community pharmacy enhanced services

Incorporation and Impact of a Clinical Pharmacist in a Hospital-Based Neurology Clinic Treating Patients with Multiple Sclerosis

Contact Info

Product

Resources

About